Ken Fisher's BMRN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 31,726 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $1.72 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Ken Fisher has maintained this position in BMRN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 18,181 shares. Largest reduction occurred in Q1 2025, reducing 393 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +13,490 | New Buy | 13,490 | $96.42 |
| Q1 2024 | +9 | Add 0.07% | 13,499 | $87.34 |
| Q2 2024 | -75 | Reduce 0.56% | 13,424 | $82.34 |
| Q3 2024 | +122 | Add 0.91% | 13,546 | $70.29 |
| Q4 2024 | +420 | Add 3.10% | 13,966 | $65.73 |
| Q1 2025 | -393 | Reduce 2.81% | 13,573 | $70.69 |
| Q2 2025 | -28 | Reduce 0.21% | 13,545 | $54.97 |
| Q3 2025 | +18,181 | Add 134.23% | 31,726 | $54.16 |
Ken Fisher's BioMarin Pharmaceutical Investment FAQs
Ken Fisher first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q4 2023, acquiring 13,490 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held BioMarin Pharmaceutical Inc. (BMRN) for 8 quarters since Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q3 2025, adding 31,726 shares worth $1.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 31,726 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $1.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 31,726 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.